Life-Sciences-Benelux.com
The Benelux Life Sciences Web Portal

This is a free web portal for the life sciences in Belgium, The Netherlands and Luxembourg... » read more

Qiagen Announces Collaboration with Nvidia at Bio-IT World (2026-05-19)
> Collaboration integrates NVIDIA accelerated computing and the NVIDIA BioNeMo platform with QIAGEN Digital Insights’ curated biomedical knowledge bases > Goal to advance how disease mechanisms, therapeutic targets and biomarkers are identified > Graph-base...
Scarlet Therapeutics Closes £3.2m Seed Round Led by Eos (2026-05-07)
£3.2M Seed Round Closed to Accelerate Platform Development Scarlet Therapeutics (“Scarlet”) today announces a landmark preclinical result: its proprietary cell-line derived, universal, lab-grown red blood cells (“RBCs”) have successfully matured and c...
CellCentric Announces $220m Series D Led by Venrock (2026-05-06)
> Proceeds to support registration-enabling trials, DOMMINO-1 and DOMMINO-2, and continued development of the first-in-class p300/CBP inhibitor > Financing led by Venrock Healthcare Capital Partners, with participation from Fidelity Management & Research Company...
UCB to Acquire Candid Therapeutics for up $2.2b (2026-05-03)
> Deal builds upon UCB’s position as a leader in immunology innovation and expands capabilities in next-generation biologics with potential for immune reset > Candid’s lead asset, cizutamig, a bispecific antibody directed to B-cell maturation antigen (BCMA) ...
UCB Has Acquired the IMIDomics’ Patient Insight Business (2026-05-01)
> UCB acquires IMIDomics’ Patient Insight Business, gaining access to one of the world’s most comprehensive multi omic datasets for immune mediated inflammatory diseases > Patient Insight Business enhances UCB’s ability to identify novel drug targets, disc...
CARB-X Awards Funding to AdJane to Advance Gonorrhea Vaccine (2026-04-28)
Heterologous approach aims to deliver targeted, broad-spectrum immune response to Neisseria gonorrhoeaeinfections Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) is awarding US$2.6 million to AdJane to advance the development of ...
Coultreon’s $125m Series A Is Led by Sofinnova Investments (2026-04-28)
> Financing led by Sofinnova Investments and co-led by Forbion and Novo Holdings > Proceeds to advance lead immunology program COL-5671, a potential first-in-class, oral once-daily therapy, across a range of auto-immune indications Coultreon Biopharma (form...
UCB to Acquire Neurona Therapeutics for up to $1.15b (2026-04-17)
> Acquisition builds on UCB’s 30-year heritage and leadership as an innovator in epilepsy and accelerates entry into next generation disease-modifying therapies. > Lead investigational asset, NRTX-1001, a neuronal cell therapy, is being evaluated in phase I/II...
Tibeay Biosciences Raises €35m Round Led by Athos (2026-04-15)
Funding supports a European, pivotal registrational trial targeting secondary brain damage in patients with severe traumatic brain injury > Financing of EUR 35 million led by ATHOS KG, with participation from MIG, Meneldor and Oost NL > Proceeds will support ...
Adcendo Closes $75m Series C Led by Jeito Capital (2026-04-14)
> Oversubscribed financing led by Jeito Capital, including additional new investment from Vida Ventures, BPI France, and EIFO, with participation from all existing investors > Proceeds to support the advancement of three first- and best-in-class ADC programs thr...

Life-Sciences-Benelux.com is your doorway to the Benelux life sciences!

[LSBNL] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in the Benelux countries Belgium, The Netherlands and Luxembourg.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSBNL] is 100% Made in Germany!

» Start here with the latest News!

Picture EBD Group BIO-Europe 2026 Köln Cologne to 31 Jul 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)